ArticleBMJ open2026

Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol.

Jin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.